Advertisement

Cytotechnology

, Volume 65, Issue 1, pp 105–118 | Cite as

Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials

  • Mikako SaitoEmail author
  • Aya Hayakawa
  • Nobuya Inagaki
  • Hideaki Matsuoka
Original Research

Abstract

Pdx-1 and Irs-1, genes highly associated with diabetes onset, were knocked down in mouse embryonic stem (ES) cells in order to develop cell line models for diabetes. ES cells with different gene knockdown levels were induced to differentiate to the stage of insulin production. Among the cell lines that differentiated, we identified two in which the levels of expression of both genes were 20–40 % of that of control cells. These cell lines showed appreciable deficiencies in three characteristic malfunctions associated with diabetes, namely, insulin production, insulin reception signaling, and glucose-stimulated insulin secretion. These dysfunctions were consistent with results reported elsewhere from in vivo and in vitro studies. Both cell lines did not show any abnormal morphology such as size, shape, color, and surface roughness. No abnormal expression profiles for 17 genes relevant to diabetes were observed. Therefore, these cell lines fulfilled the criteria for a validated cell model for diabetes. The model cell lines developed here are promising biomaterials for cell-based screening tests of new medicines that may be effective in treating diabetes.

Keywords

Diabetic dysfunction model cell Cell-based screening test Mouse embryonic stem cell Double knockdown Validation 

Notes

Acknowledgments

We thank Dr. Niwa for the donation of feeder free EB3 cells. This work was partially funded by a grant to H. Matsuoka from CREST of Japan Science and Technology Agency on the research subject: The High Throughput Creation of Disease Model Cells and the Analysis of Their Function. The work was also supported in part by the Strategic Research Promotion Program, the Ministry of Education, Culture, Sports, Science, and Technology, on the research subject “Development of Next Generation Bioresources”.

References

  1. Bennett K, James C, Hussain K (2010) Pancreatic β-cell KATP channels: hypoglycaemia and hyperglycaemia. Rev. Endocr. Metab. Disord. 11:157–163CrossRefGoogle Scholar
  2. Chalk AM, Wahlestedt C, Sonnhammer EL (2004) Improved and automated prediction of effective siRNA. Biochem Biophys Res Commun 319:264–274CrossRefGoogle Scholar
  3. Dobrzyn P, Jazurek M, Dobrzyn A (2010) Stearoyl-CoA desaturase and insulin signaling - what is the molecular switch? Biochim Biophys Acta 1797:1189–1194CrossRefGoogle Scholar
  4. Franchini M, Monnais E, Seboek D, Radimerski T, Zini E, Kaufmann K, Lutz T, Reusch C, Ackermann M, Muller B, Linscheid P (2010) Insulin resistance and increased lipolysis in bone marrow derived adipocytes stimulated with agonists of toll-like receptors. Horm Metab Res 42:703–709CrossRefGoogle Scholar
  5. Gannon M, Ables ET, Crawford L, Lowe D, Offield MF, Magnuson MA, Wright CV (2008) Pdx-1 function is specifically required in embryonic beta-cells to generate appropriate numbers of endocrine cells types and maintain glucose homeostasis. Dev. Biol. 314:406–417CrossRefGoogle Scholar
  6. González-Rodríguez Á, Gutierrez JAM, Sanz-González S, Ros M, Burks DJ, Valverde ÁM (2010) Inhibition of PTP1B Restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes 59:588–599CrossRefGoogle Scholar
  7. Guo S, Copps KD, Dong X, Park S, Cheng Z, Pocai A, Rossetti L, Sajan M, Farese RV, White MF (2009) The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol Cell Biol 29:5070–5083CrossRefGoogle Scholar
  8. Ketsawatsomkron P, Stepp DW, Fulton DJ, Marrero MB (2010) Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: roles of protein tyrosine phosphatase-1B. Vascul Pharmacol 53:160–168CrossRefGoogle Scholar
  9. Kubota N, Kubota T, Itoh S, Kumagai H, Kozono H, Takamoto I, Mineyama T, Ogata H, Tokuyama K, Ohsugi M, Sasako T, Moroi M, Sugi K, Kakuta S, Iwakura Y, Noda T, Ohnishi S, Nagai R, Tobe K, Terauchi Y, Ueki K, Kadowaki T (2008) Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab 8:49–64CrossRefGoogle Scholar
  10. Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR (2004) PDX-1 haploinsufficiency limits the compensatory Islet hyperplasia that occurs in response to insulin resistance. J. Clin. Invest. 114:828–836Google Scholar
  11. Li F, Mahato RI (2011) RNA interference for improving the outcome of islet transplantation. Adv Drug Deliv Rev 63:47–68CrossRefGoogle Scholar
  12. McKinnon CM, Docherty K (2001) Pancreatic duodenal homeobox-1, Pdx-1, a major regulator of beta cell identity and function. Diabetologia 44:1203–1214CrossRefGoogle Scholar
  13. Melloul D, Marshak S, Cerasi E (2001) Regulation of insulin gene transcription. Diabetologia 45:309–326CrossRefGoogle Scholar
  14. Melloul D, Marshak S, Cerasi E (2002) Regulation of Pdx-1 gene expression. Diabetes 51:S320–325CrossRefGoogle Scholar
  15. Moritoh Y, Yamato E, Yasui Y, Miyazaki S, Miyazaki J (2003) Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 52:1163–1168CrossRefGoogle Scholar
  16. Pal M (2009) Recent advances in glucokinase activators for the treatment of type 2 diabetes. Drug Discovery Today 14:784–792CrossRefGoogle Scholar
  17. Santoyo J, Vaquerizas JM, Dopazo J (2005) Highly specific and accurate selection of siRNAs for high-throughput functional assays. Bioinformatics 21:1376–1382CrossRefGoogle Scholar
  18. Shih DQ, Heimesaat M, Kuwajima S, Stein R, Wright CV, Stoffel M (2002) Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta. Proc. Natl. Acad. Sci. USA 99:3818–3823CrossRefGoogle Scholar
  19. Sliva K, Schnierle BS (2010) Selective gene silencing by viral delivery of short hairpin RNA. Virol. J. 7:248–258CrossRefGoogle Scholar
  20. Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, Kanazawa Y, Asanuma N, Aizawa T, Akanuma Y, Yasuda K, Kodama T, Tobe K, Yazaki Y, Kadowaki T (1997) Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J. Clin. Invest. 99:861–866CrossRefGoogle Scholar
  21. Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T (2007) Glucokinase and IRS-2 are required for compensatory β-cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Invest. 117:246–257CrossRefGoogle Scholar
  22. Wada T, Ohshima S, Fujisawa E, Koya D, Tsuneki H, Sasaoka T (2009) Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes. Endocrinology 150:1662–1669CrossRefGoogle Scholar
  23. Watada H, Kajimoto Y, Umayahara Y, Matsuoka T, Kaneto H, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y (1996) The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes 45:1478–1488CrossRefGoogle Scholar
  24. Yang X, Nath A, Opperman MJ, Chan C (2010) The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Mol Biol Cell 21:3449–3458CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Mikako Saito
    • 1
    Email author
  • Aya Hayakawa
    • 1
  • Nobuya Inagaki
    • 2
  • Hideaki Matsuoka
    • 1
  1. 1.Department of Biotechnology and Life ScienceTokyo University of Agriculture and TechnologyKoganei, TokyoJapan
  2. 2.Department of Diabetes and Clinical Nutrition, Graduate School of MedicineKyoto UniversitySakyo-ku, KyotoJapan

Personalised recommendations